A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
The study hypothesis is to establish the safety and tolerability of long-term open-label (OL) CP-690,550 therapy in subjects with Crohn's disease.
Inclusion Criteria:
Exclusion Criteria:
Milwaukee, Wisconsin 53215, United States
Kolonaki Athens, 106 76, Greece
Budapest, 1076, Hungary
Odesa, 65117, Ukraine